Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human β-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays

…, Y Laras, R Rosas, G Herbette, B Maigret…

Index: Garino, Cedrik; Tomita, Taisuke; Pietrancosta, Nicolas; Laras, Younes; Rosas, Roselyne; Herbette, Gaetan; Maigret, Bernard; Quelever, Gilles; Iwatsubo, Takeshi; Kraus, Jean-Louis Journal of Medicinal Chemistry, 2006 , vol. 49, # 14 p. 4275 - 4285

Full Text: HTML

Citation Number: 57

Abstract

Twenty novel β-secretase inhibitors containing biarylpiperazine moieties belonging to naphthyl and coumarinyl series were designed for their potential use in Alzheimer's disease therapy. Enzymatic and cell-based assays have been carried out. The biological results clearly demonstrate that specific substituents located at the N4-position of the piperazine ring result in excellent in vitro inhibitory potency (IC50 values ranging between 40 and 70 ...

Related Articles:

Phenylimino-2H-chromen-3-carboxamide derivatives as novel small molecule inhibitors of β-secretase (BACE1)

[Edraki, Najmeh; Firuzi, Omidreza; Foroumadi, Alireza; Miri, Ramin; Madadkar-Sobhani, Armin; Khoshneviszadeh, Mehdi; Shafiee, Abbas Bioorganic and Medicinal Chemistry, 2013 , vol. 21, # 8 p. 2396 - 2412]

More Articles...